Trial Profile
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ReaL
- Sponsors Novo Nordisk
- 01 Jun 2018 Results (n=1325) published in the Acta Diabetologica.
- 12 Dec 2017 Results published in the Advances in Therapy
- 19 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.